Skip to content

Clinical trials

Phase 2 Gastroparesis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroparesis Phase: Phase 2 Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20093
20101
20112
20124
20132
20142
20151
20162
20171
20195
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated7
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tranzyme, Inc.4
CinDome Pharma, Inc.3
GlaxoSmithKline3
Johns Hopkins University2
Mayo Clinic2
Allergan1
Chugai Pharma USA1
Dr. Falk Pharma GmbH1
Evoke Pharma1
Indiana University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroparesis30
Diabetes Mellitus8
Vomiting4
Diabetes Mellitus, Type 23
Nausea3
Diabetes Complications2
Diabetes Mellitus, Type 12
Gastroesophageal Reflux2
Pancreatitis2
Respiratory Insufficiency2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.